Human-Centered Artificial Intelligence Framework for Overdose Mortality Surveillance, New York City, 2022‒2023.

Saved in:
Bibliographic Details
Title: Human-Centered Artificial Intelligence Framework for Overdose Mortality Surveillance, New York City, 2022‒2023.
Authors: Hochstatter, Karli R., Nadel, Talia, Gupta, Raavi, Jangra, Anubhav, D'Anna, Nicole, Gryczynski, Jan, Li, Yuxin, Graham, Jason, Johnson, Hannah, El-Bassel, Nabila, Yang, Ziqing, Muresan, Smaranda
Source: American Journal of Public Health. Oct2026, Vol. 116 Issue 10, p1565-1574. 10p.
Subjects: Drug overdose, Public health surveillance, Predictive tests, Prediction models, Research funding, Artificial intelligence, Forensic sciences, Logistic regression analysis, Descriptive statistics, Natural language processing, Conceptual structures, Mathematical models, Theory, Software architecture, Algorithms, Sensitivity & specificity (Statistics)
Geographic Terms: New York (State)
Abstract: Objectives. To develop and evaluate human-centered artificial intelligence (AI) models that identify suspected overdose deaths using narrative reports from medicolegal death investigations and describe ethical considerations for using AI in overdose surveillance. Methods. We trained AI models using 2022–2023 data from the New York City Office of Chief Medical Examiner (OCME). Narrative death investigation reports (n = 9263) were analyzed using a 2-step pipeline that first extracted textual evidence for 18 expert-defined indicators of overdose and then predicted overdose using 2 large language model families: LLaMA-8B-Instruct and ClinicalModernBERT. Domain experts provided feedback throughout model development, and safeguards were implemented to protect confidentiality and evaluate algorithmic bias. Results. The LLaMA-8B-Instruct model achieved 88% positive predictive value (PPV), 92% sensitivity, 84% negative predictive value (NPV), 76% specificity, and 85% macro-F1. The ClinicalModernBERT model achieved 83% PPV, 92% sensitivity, 82% NPV, 67% specificity, and 81% macro-F1. Both AI models outperformed OCME's existing surveillance tool and conventional logistic regression approaches. Conclusions. Human-centered AI may support timely and accurate overdose surveillance, but responsible implementation requires expert oversight, a privacy-compliant infrastructure, and ongoing evaluation of potential bias. (Am J Public Health. 2026;116(10):1565–1574. https://doi.org/10.2105/AJPH.2026.308698) [ABSTRACT FROM AUTHOR]
Copyright of American Journal of Public Health is the property of American Public Health Association and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:Objectives. To develop and evaluate human-centered artificial intelligence (AI) models that identify suspected overdose deaths using narrative reports from medicolegal death investigations and describe ethical considerations for using AI in overdose surveillance. Methods. We trained AI models using 2022–2023 data from the New York City Office of Chief Medical Examiner (OCME). Narrative death investigation reports (n = 9263) were analyzed using a 2-step pipeline that first extracted textual evidence for 18 expert-defined indicators of overdose and then predicted overdose using 2 large language model families: LLaMA-8B-Instruct and ClinicalModernBERT. Domain experts provided feedback throughout model development, and safeguards were implemented to protect confidentiality and evaluate algorithmic bias. Results. The LLaMA-8B-Instruct model achieved 88% positive predictive value (PPV), 92% sensitivity, 84% negative predictive value (NPV), 76% specificity, and 85% macro-F1. The ClinicalModernBERT model achieved 83% PPV, 92% sensitivity, 82% NPV, 67% specificity, and 81% macro-F1. Both AI models outperformed OCME's existing surveillance tool and conventional logistic regression approaches. Conclusions. Human-centered AI may support timely and accurate overdose surveillance, but responsible implementation requires expert oversight, a privacy-compliant infrastructure, and ongoing evaluation of potential bias. (Am J Public Health. 2026;116(10):1565–1574. https://doi.org/10.2105/AJPH.2026.308698) [ABSTRACT FROM AUTHOR]
ISSN:00900036
DOI:10.2105/AJPH.2026.308698